Clinical Trial Update: 131I-IPA and Concurrent XRT in Recurrent GBM [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating 131I-IPA with concurrent radiotherapy in recurrent glioblastoma multiforme.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• 131I-IPA

Snippet

Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited | Conditions: Glioblastoma Multiforme | Phase 1, Phase 2 | Status: COMPLETED